Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cohn

Showing results (631-640 of 730) with videos related to

Pageof 73
Sort By:
Contraception|February 14, 2023
Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic studyLauren R Cirrincione, Shadia Nakalema, Catherine A Chappell, et al.
Gynecologic Oncology|November 10, 2021
Aberrant expression of TMEM205 signaling promotes platinum resistance in ovarian cancer: An implication for the antitumor potential of DAP compoundCorinne A Calo, Brentley Q Smith, Kalpana Deepa Priya Dorayappan, et al.
Oncogene|October 16, 2024
Obesity-induced extracellular vesicles proteins drive the endometrial cancer pathogenesis: therapeutic potential of HO-3867 and MetforminTakahiko Sakaue, Kalpana Deepa Priya Dorayappan, Roman Zingarelli, et al.
Gynecologic Oncology|March 29, 2026
Implementing non-invasive biospecimen collection in gynecologic oncology: Insights from a prospective gut microbiome feasibility studyJulia Chalif, Catherine Moruzzi, Jessica Velasquez, et al.
Frontiers in Genetics|June 6, 2022
Genetic and Epigenetic Mechanisms Deregulate the CRL2<sup>pVHL</sup> Complex in Hepatocellular CarcinomaBrenda C Minatel, David E Cohn, Michelle E Pewarchuk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2010
REO-10: a phase I study of intravenous reovirus and docetaxel in patients with advanced cancerCharles Comins, James Spicer, Andrew Protheroe, et al.
Gynecologic Oncology|June 1, 2025
The impact of antibiotics, proton pump inhibitors, H2-receptor antagonists, and steroids on survival in ovarian cancer patients receiving PARP inhibitor therapyQuinn Kistenfeger, Paulina J Haight, Monica Levine, et al.
American Journal of Obstetrics and Gynecology|May 29, 2019
Miscarriage among women in the United States Women's Interagency HIV Study, 1994-2017Kristin M Wall, Lisa B Haddad, C Christina Mehta, et al.
The Journal of Infectious Diseases|December 16, 2003
Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletionHoward M Lederman, Paige L Williams, Julia W Wu, et al.
Gynecologic Oncology|December 17, 2003
Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapyWarner K Huh, Matthew Powell, Charles A Leath, et al.
Pageof 73

Showing results (631-640 of 730) with videos related to

Sort By:
Pageof 73
Contraception|February 14, 2023
Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic studyLauren R Cirrincione, Shadia Nakalema, Catherine A Chappell, et al.
Gynecologic Oncology|November 10, 2021
Aberrant expression of TMEM205 signaling promotes platinum resistance in ovarian cancer: An implication for the antitumor potential of DAP compoundCorinne A Calo, Brentley Q Smith, Kalpana Deepa Priya Dorayappan, et al.
Oncogene|October 16, 2024
Obesity-induced extracellular vesicles proteins drive the endometrial cancer pathogenesis: therapeutic potential of HO-3867 and MetforminTakahiko Sakaue, Kalpana Deepa Priya Dorayappan, Roman Zingarelli, et al.
Gynecologic Oncology|March 29, 2026
Implementing non-invasive biospecimen collection in gynecologic oncology: Insights from a prospective gut microbiome feasibility studyJulia Chalif, Catherine Moruzzi, Jessica Velasquez, et al.
Frontiers in Genetics|June 6, 2022
Genetic and Epigenetic Mechanisms Deregulate the CRL2<sup>pVHL</sup> Complex in Hepatocellular CarcinomaBrenda C Minatel, David E Cohn, Michelle E Pewarchuk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2010
REO-10: a phase I study of intravenous reovirus and docetaxel in patients with advanced cancerCharles Comins, James Spicer, Andrew Protheroe, et al.
Gynecologic Oncology|June 1, 2025
The impact of antibiotics, proton pump inhibitors, H2-receptor antagonists, and steroids on survival in ovarian cancer patients receiving PARP inhibitor therapyQuinn Kistenfeger, Paulina J Haight, Monica Levine, et al.
American Journal of Obstetrics and Gynecology|May 29, 2019
Miscarriage among women in the United States Women's Interagency HIV Study, 1994-2017Kristin M Wall, Lisa B Haddad, C Christina Mehta, et al.
The Journal of Infectious Diseases|December 16, 2003
Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletionHoward M Lederman, Paige L Williams, Julia W Wu, et al.
Gynecologic Oncology|December 17, 2003
Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapyWarner K Huh, Matthew Powell, Charles A Leath, et al.
Pageof 73